Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M37.6Revenue $M3.5Net Margin (%)-461.4Z-Score-3.5
Enterprise Value $M26.0EPS $-0.4Operating Margin %-445.4F-Score2
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-461.3Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %0Quick Ratio6.3Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio6.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-102.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)-188.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M50.8ROI % (ttm)-161.1Gross Margin Increase y-yN

Gurus Latest Trades with NBY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

NBY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


NBY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SIECZKAREK MARK MDirector 2014-06-04Buy4,800$0.89-15.73 view
SIECZKAREK MARK MDirector 2014-05-19Buy25,000$0.88-14.77 view
China Pioneer Pharma Holdings 10% Owner 2014-05-13Buy65,065$0.99-24.24 view
China Pioneer Pharma Holdings 10% Owner 2014-05-12Buy116,107$0.99-24.24 view
China Pioneer Pharma Holdings 10% Owner 2014-05-09Buy318,828$0.99-24.24 view
China Pioneer Pharma Holdings 10% Owner 2013-12-02Buy5,000,000$1.14-34.21 view
Pioneer Pharma (Hong Kong) Co 10% Owner 2013-12-02Buy5,000,000$1.14-34.21 view
Pioneer Pharma (Singapore) Pte10% Owner 2013-12-02Buy5,000,000$1.14-34.21 view
China Pioneer Pharma Holdings 10% Owner 2013-11-14Buy108,156$1.02-26.47 view
Li Xinzhou10% Owner 2013-09-20Sell120,000$1.87-59.89 view

Press Releases about NBY :

    Quarterly/Annual Reports about NBY:

    News about NBY:

    Articles On GuruFocus.com
    Own it Feb 29 2012 
    NovaBay Pharmaceuticals Inc. (NBY) Chairman Ramin Najafi buys 1,000 Shares Aug 28 2009 
    NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results Aug 14 2009 

    More From Our Partners
    Morning Market Losers Aug 20 2014 - BENZINGA

    More From Other Websites
    Why NovaBay Pharmaceuticals (NBY) Stock Plummeted to a One-Year Low Today Aug 20 2014
    Rancho Mirage, California Physician Saves Casino Worker from Deadly 'Flesh Eating Disease' Aug 20 2014
    NovaBay Announces Results of NVC-422 Phase 2 For Viral Conjunctivitis Aug 20 2014
    7:01 am NovaBay Pharma announces its NVC-422 ophthalmic formulation did not meet the primary or... Aug 20 2014
    NovaBay Announces Results of NVC-422 Phase 2 for Viral Conjunctivitis Aug 20 2014
    NovaBay Announces Results of NVC-422 Phase 2 for Viral Conjunctivitis Aug 20 2014
    National Necrotizing Fasciitis Foundation Warns Watch Out For Vibrio Infections Aug 12 2014
    NOVABAY PHARMACEUTICALS, INC. Financials Aug 09 2014
    NovaBay Pharmaceuticals Reports Second Quarter 2014 Financial Results and a Clinical/Business Update Jul 31 2014
    NovaBay Pharmaceuticals Reports Second Quarter 2014 Financial Results and a Clinical/Business Update Jul 31 2014
    NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Jul 31 2014
    In RadioMD Interview, Dr. John Crew Describes Successful New Treatment for Flesh-Eating Disease Jul 24 2014
    NovaBay Pharmaceuticals Announces Direct US Marketing-Sales Campaign For New i-LidTM Cleanser... Jul 16 2014
    NovaBay Pharmaceuticals Announces Direct US Marketing-Sales Campaign for New i-LidTM Cleanser... Jul 16 2014
    Letter to NovaBay Shareholders Jul 10 2014
    Letter to NovaBay Shareholders Jul 10 2014
    Letter to NovaBay Shareholders Jul 10 2014
    NovaBay’s New Product for Serious Eye Conditions Highlighted in CEOLIVE.TV Interview Jul 03 2014
    NovaBay’s New Product for Serious Eye Conditions Highlighted in CEOLIVE.TV Interview Jul 03 2014
    British Prime Minister David Cameron Warns of Growing Crisis of Antibiotic-Resistant Bacteria, But... Jul 02 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide